SuperworthIronwood Pharmaceuticals shares outstanding IRWD
Diluted shares outstanding, averaged over each quarter, from 2010.
- Latest quarter, to Jun 30, 2026
- 167.2M
- On a year earlier
- −5.5%
- fewer shares
Ironwood Pharmaceuticals had 167.2M diluted shares outstanding on average in Q2 FY26, the quarter to Jun 30, 2026.
That is 5.5% fewer than a year earlier, so each share owns a little more of the company.
Shares outstanding over time
Fiscal year by fiscal year
| Fiscal year | Shares, fourth quarter | Change |
|---|---|---|
| FY2025 | 162.4M | +1% |
| FY2024 | 160.9M | +3% |
| FY2023 | 156M | −16% |
| FY2022 | 185.7M | +12% |
| FY2021 | 165.9M | +2% |
| FY2020 | 161.8M | +5% |
| FY2019 | 153.6M | −0% |
| FY2018 | 154.1M | +3% |
| FY2017 | 149.9M | +2% |
| FY2016 | 146.3M | +2% |
| FY2015 | 142.8M | +2% |
| FY2014 | 139.8M | +16% |
| FY2013 | 120.9M | +13% |
| FY2012 | 107.5M | +7% |
| FY2011 | 100.4M | +2% |
Each fiscal year is the twelve months to its fourth quarter, shown as the fourth quarter's average share count.
Quarter by quarter
| Quarter | Ended | Shares outstanding | On a year earlier |
|---|---|---|---|
| Q2 FY26 | 167.2M | −5% | |
| Q1 FY26 | 166.7M | +4% | |
| Q4 FY25 | 162.4M | +1% | |
| Q3 FY25 | 177.8M | +11% | |
| Q2 FY25 | 176.8M | +11% | |
| Q1 FY25 | 161M | +2% | |
| Q4 FY24 | 160.9M | +3% | |
| Q3 FY24 | 160.2M | −14% | |
| Q2 FY24 | 159M | +2% | |
| Q1 FY24 | 157.7M | −16% | |
| Q4 FY23 | 156M | −16% | |
| Q3 FY23 | 186.9M | +1% |
What the shares outstanding tells you
Diluted shares outstanding, averaged over the period. Fewer shares means each one owns more of the company.
A falling count usually means buybacks. A rising one means stock pay, acquisitions paid in shares or new shares sold.
More on Ironwood Pharmaceuticals
Valuation data, not investment advice. Prices as of . Reported figures come from the company's filings with the SEC.